Skip to main content

Atrophic Acne Scar

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Deka Biosciences
Deka BiosciencesMD - Germantown
1 program
LasersN/A1 trial
Active Trials
NCT03809416CompletedEst. Oct 2019
Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
Nonablative fractional laserN/A1 trial
Active Trials
NCT05105334Unknown20Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fitzpatrick CompanyNonablative fractional laser
Deka BiosciencesLasers

Clinical Trials (2)

Total enrollment: 20 patients across 2 trials

NCT05105334Fitzpatrick CompanyNonablative fractional laser

Combined Therapy for Acne Scars

Start: Nov 2021Est. completion: Jul 202220 patients
N/AUnknown

Combined LASERs and PRP for Postacne Scars

Start: Oct 2018Est. completion: Oct 2019
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.